{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:31:54Z","timestamp":1792834314764,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["PRIN 2022 2022ETPX42"],"award-info":[{"award-number":["PRIN 2022 2022ETPX42"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell&apos;Istruzione dell&apos;Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG 26290"],"award-info":[{"award-number":["IG 26290"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG 23539"],"award-info":[{"award-number":["IG 23539"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218284","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:21:46Z","timestamp":1769732506000},"page":"218284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["MEOX2 enhances DNA repair and therapy resistance in Glioblastoma stem-like cells via PARP1 interaction"],"prefix":"10.1016","volume":"642","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3639-8983","authenticated-orcid":false,"given":"Monia","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvia","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Aliperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Copparoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1663-6364","authenticated-orcid":false,"given":"Amanda","family":"Linkous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-7176","authenticated-orcid":false,"given":"Claudia","family":"Montaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Soddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Maxime","family":"Besson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-4657","authenticated-orcid":false,"given":"Marie","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-7504","authenticated-orcid":false,"given":"Manuela","family":"Helmer Citterich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9133-8482","authenticated-orcid":false,"given":"Alessandro","family":"Michienzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6467-8396","authenticated-orcid":false,"given":"Silvia Anna","family":"Ciafr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3646-4064","authenticated-orcid":false,"given":"Silvia","family":"Galardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canlet.2026.218284_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2026.218284_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1476-4598-9-234","article-title":"An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients","volume":"9","author":"Ducray","year":"2010","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2026.218284_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.3390\/cancers14092304","article-title":"MEOX2 regulates the growth and survival of glioblastoma stem cells by modulating genes of the glycolytic pathway and response to hypoxia","volume":"14","author":"Proserpio","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.canlet.2026.218284_bib4","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/neuonc\/noac110","article-title":"MEOX2 homeobox gene promotes growth of malignant gliomas","volume":"24","author":"Sch\u00f6nrock","year":"2022","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218284_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/neuonc\/noae011","article-title":"Cancer stem cell hypothesis 2.0 in glioblastoma: where are we now and where are we going?","volume":"26","author":"Sloan","year":"2024","journal-title":"Neuro Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218284_bib6","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.molcel.2022.02.021","article-title":"The expanding universe of PARP1-mediated molecular and therapeutic mechanisms","volume":"82","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.canlet.2026.218284_bib7","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","article-title":"Modeling patient-derived glioblastoma with cerebral organoids","volume":"26","author":"Linkous","year":"2019","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.canlet.2026.218284_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/2159-8290.CD-20-0057","article-title":"Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas","volume":"10","author":"Pine","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.canlet.2026.218284_bib9","article-title":"Elucidating the mechanisms of temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218284_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.freeradbiomed.2020.04.026","article-title":"A combined \u03b3-H2AX and 53BP1 approach to determine the DNA damage-repair response to exercise in hypoxia","volume":"154","author":"Williamson","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.canlet.2026.218284_bib11","first-page":"1957","article-title":"p53 effects both the duration of G2\/M arrest and the fate of temozolomide-treated human glioblastoma cells","volume":"61","author":"Hirose","year":"2001","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2026.218284_bib12","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41416-023-02402-y","article-title":"Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers","volume":"129","author":"Ntafoulis","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218284_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41420-025-02517-6","article-title":"Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1\/miR-26a-1\/miR-487b signature mediated WT1 and FOXA1 silencing","volume":"11","author":"D\u00edaz M\u00e9ndez","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2026.218284_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1476-4598-10-128","article-title":"Chemoresistance of glioblastoma cancer stem cells--much more complex than expected","volume":"10","author":"Beier","year":"2011","journal-title":"Mol. Cancer"},{"issue":"15","key":"10.1016\/j.canlet.2026.218284_bib15","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1158\/0008-5472.CAN-14-3616","article-title":"Minor changes in expression of the mismatch repair protein MSH2 exert a major impact on glioblastoma response to temozolomide","volume":"75","author":"McFaline-Figueroa","year":"2015","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218284_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000397","article-title":"Genome-wide analysis of histidine repeats reveals their role in the localization of human proteins to the nuclear speckles compartment","volume":"5","author":"Salichs","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.canlet.2026.218284_bib17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fgene.2019.00906","article-title":"A novel prognostic signature of transcription factors for the prediction in patients with GBM","volume":"10","author":"Cheng","year":"2019","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.canlet.2026.218284_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3390\/genes16080861","article-title":"Construction of a genetic prognostic model in the glioblastoma tumor microenvironment","volume":"16","author":"Wu","year":"2025","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.canlet.2026.218284_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41379-018-0192-6","article-title":"Prognostic significance of MEOX2 in gliomas","volume":"32","author":"Tachon","year":"2019","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218284_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.12.002","article-title":"MEOX2 promotes glioma growth and temozolomide chemoresistance","volume":"14","author":"Li","year":"2024","journal-title":"J. Pharm. Anal."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:24:53Z","timestamp":1773998693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"alternative-id":["S0304383526000479"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218284","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEOX2 enhances DNA repair and therapy resistance in Glioblastoma stem-like cells via PARP1 interaction","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218284"}}